PMID- 22685335 OWN - NLM STAT- MEDLINE DCOM- 20121210 LR - 20220309 IS - 1479-6805 (Electronic) IS - 0022-0795 (Linking) VI - 214 IP - 3 DP - 2012 Sep TI - In vivo studies on non-viral transdifferentiation of liver cells towards pancreatic beta cells. PG - 277-88 AB - Transdifferentiation in vivo is an attractive option for autologous replacement of pancreatic beta cells in patients with type 1 diabetes. It has been achieved by adenoviral delivery of genes for transcription factors in the liver and pancreas of hyperglycaemic mice. However, these viral approaches are not clinically applicable. We used the hydrodynamic approach to deliver genes Pdx1, Ngn3 (Neurog3) and MafA singly and in combination to livers of normoglycaemic rats. Five expression plasmids were evaluated. Livers were removed 1, 3, 7, 14 and 28 days after gene delivery and assayed by quantitative PCR, semi-quantitative PCR and immunohistology. Functional studies on hyperglycaemic rats were performed. The highest and most sustained expression was from a CpG-depleted plasmid (pCpG) and a plasmid with an in-frame scaffold/matrix attachment region ((pEPI(CMV)). When Pdx1, Ngn3 and MafA were delivered together to normoglycaemic rats with these plasmids, insulin mRNA was detected at all time points and was ~50-fold higher with pCpG. Insulin mRNA content of livers at days 3 and 7 was equivalent to that of a pancreas, with scattered insulin-positive cells detected by immunohistology, but levels declined thereafter. Prohormone convertase 1/3 was elevated at days 3 and 7. In hyperglycaemic rats, fasting blood glucose was lower at days 1, 3 and 7 but not thereafter, and body weight was maintained to day 28. We conclude that hydrodynamic gene delivery of multiple transcription factors to rat liver can initiate transdifferentiation to pancreatic beta cells, but the process is reversible and probably requires more sustained transcription factor expression. FAU - Cim, Abdullah AU - Cim A AD - Department of Hepatology and Transplantation, King's College London School of Medicine, James Black Centre, London SE5 9NU, UK. FAU - Sawyer, Greta J AU - Sawyer GJ FAU - Zhang, Xiaohong AU - Zhang X FAU - Su, Haibin AU - Su H FAU - Collins, Louise AU - Collins L FAU - Jones, Peter AU - Jones P FAU - Antoniou, Michael AU - Antoniou M FAU - Reynes, Jean-Paul AU - Reynes JP FAU - Lipps, Hans-Joachim AU - Lipps HJ FAU - Fabre, John W AU - Fabre JW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120608 PL - England TA - J Endocrinol JT - The Journal of endocrinology JID - 0375363 RN - 0 (Basic Helix-Loop-Helix Transcription Factors) RN - 0 (Homeodomain Proteins) RN - 0 (Insulin) RN - 0 (Maf Transcription Factors, Large) RN - 0 (Mafa protein, mouse) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neurog3 protein, mouse) RN - 0 (Trans-Activators) RN - 0 (pancreatic and duodenal homeobox 1 protein) SB - IM MH - Animals MH - Basic Helix-Loop-Helix Transcription Factors/genetics MH - Cell Differentiation/*genetics MH - Diabetes Mellitus, Experimental/therapy MH - Diabetes Mellitus, Type 1/*therapy MH - *Gene Transfer Techniques MH - Genetic Therapy/*methods MH - Homeodomain Proteins/genetics MH - Hyperglycemia/therapy MH - Insulin/metabolism MH - Insulin-Secreting Cells/*cytology/physiology MH - Liver/*cytology/physiology MH - Maf Transcription Factors, Large/genetics MH - Male MH - Nerve Tissue Proteins/genetics MH - Pancreas/cytology/physiology MH - Plasmids/genetics MH - Rats MH - Rats, Inbred Strains MH - Trans-Activators/genetics MH - Transcription, Genetic/genetics EDAT- 2012/06/12 06:00 MHDA- 2012/12/12 06:00 CRDT- 2012/06/12 06:00 PHST- 2012/06/12 06:00 [entrez] PHST- 2012/06/12 06:00 [pubmed] PHST- 2012/12/12 06:00 [medline] AID - JOE-12-0033 [pii] AID - 10.1530/JOE-12-0033 [doi] PST - ppublish SO - J Endocrinol. 2012 Sep;214(3):277-88. doi: 10.1530/JOE-12-0033. Epub 2012 Jun 8.